^

News and Publications

ASTRO 2020 Corporate Member Virtual Press Room

View news and information from ASTRO Corporate Members via the links below. Publication of material on this page does not constitute an endorsement by ASTRO of any product or claim. Materials are posted in alphabetical order by company name.

(Last updated 10/28/20)


Blue Earth Diagnostics

  • Press Release: Blue Earth Diagnostics Highlights Presentations on Axumin® (Fluciclovine F 18) and 18F-Fluciclovine at Upcoming ASTRO Annual Meeting

Galera Therapeutics

  • Press Release: Galera Therapeutics Announces ASTRO Late-Breaker Presentation of Topline Safety and Efficacy Data from its Double-Blind, Placebo-Controlled Phase 1b/2a Clinical Trial of GC4419 in Combination with SBRT for Locally Advanced Pancreatic Cancer
  • Press Release: Galera Therapeutics Announces Positive Interim Data from First Cohort of Patients in Pilot Phase 1/2 Clinical Trial of GC4419 in Pancreatic Cancer
  • Press Release: Galera Therapeutics Announces Interim Data from Pilot Phase 1/2 Trial of GC4419 in Combination with Stereotactic Body Radiation Therapy Showed Improved Overall Survival in Patients with Locally Advanced Pancreatic Cancer

iCAD Medical

  • Press Release: New Research Presented at Virtual ASTRO Meeting Supports Xoft System for Treatment of Early-Stage Breast Cancer and Gynecological Cancers 

RefleXion Medical

  • Press Release: RefleXion Highlights New Research at ASTRO 2020 Evaluating Feasibility of Biology-guided Radiotherapy to Treat Metastatic Cancer

ScandiDos

  • Press Release: ScandiDos collaborates with Accuray to provide accurate and efficient QA of moving targets